Glonghui, April 23 | Corning Jerry Pharmaceutical-B (09966.HK) announced that on April 23, 2024, according to the initial public offering after-sales share option plan, the company has decided to grant 1.18 million share options to four eligible participants (that is, employees of the Group), at an exercise price of HK$4.350 per share.
Under the restricted share award scheme, the company has decided to award a total of 130,000 award shares to two eligible participants (i.e. employees of the Group).
The purpose of granting share options and rewarding shares is to: (i) recognize share option grantees and reward the grantees for their contributions to the Group; (ii) encourage, motivate and retain grantees that contribute positively to the Group's continued operation, development and long-term growth; and (iii) closely integrate the interests of shareholders, companies and grantees and share risks with them to maximize employee motivation. The award recognises employees' past contributions to the Group's business performance and aims to obtain their long-term support and investment in the Group's future development, which is critical for the Group. The company believes that granting share options and rewarding shares is an important incentive for them to bring higher returns to the company.